In this report, the Innovation Observatory has provided a horizon scan of MedTech innovations with the potential to reduce demand for antimicrobials through SSI detection and monitoring. This landscape aims to allow the NHSE & I’s AMR Programme Board to evaluate the potential impact of these SSI innovations and to identify promising technologies for use within the NHS. Within, we report on 51 technologies across 11 countries with a particular focus on insights in monitoring innovations, tele-health, and antimicrobial susceptibility testing and pathogen detection for SSI. In addition to those technologies for use in detection and monitoring, we report on other innovations of interest (n = 118), the majority of which are intended for use in the prevention of SSI, with a select few treatment implications.
Horizon Scanning Final Report: Identification of Surgical Site Infection Technologies
Surgical site infections (SSI) are among the world’s most common healthcare-associated infections. They are associated with a host of patient quality of life concerns – e.g., higher mortality, additional surgeries, longer post-operative care – and they represent a significant economic burden to healthcare systems. These standing issues, as well as the rise in antimicrobial resistance, emphasise the importance of SSI detection and monitoring, and the continued need for new technologies that aid in both.